When a car accident or athletic injury destroys more than 20% of a muscle's mass, the body faces a problem it often can't ...

A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...

When a car accident or athletic injury destroys more than 20% of a muscle's mass, the body faces a problem it often can't ...

The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Statins have been transformative for many individuals, by lowering cholesterol and reducing the risk of heart problems and stroke. But statins can also cause muscle weakness and pain and in some cases ...

Scientists obtained stem cells expressing cardiac muscle-specific genes and proteins. The cells displayed regular rhythmic contractions similar to a heart, confirming that they were functional ...

1 Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, ...

The more we move, the more our muscle cells begin to make a memory of that exercise. MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you ...

Emma Maria Mazzenga likes to win. She once dislocated her shoulder during a race in Germany when she threw herself ahead of a competitor at the finish line. “The woman next to me was about to overtake ...

July 11 (Reuters) - The U.S. Food and Drug Administration has declined to approve Capricor Therapeutics' (CAPR.O), opens new tab cell therapy for a heart condition, the company said on Friday, sending ...

Capricor Therapeutics’ cell therapy for Duchenne muscular dystrophy has come up short at the FDA, with the regulator rejecting the biotech’s application seeking regulatory approval for what the ...